—

Nan Fung Group Holdings Ltd

Q1 2026 13F Holdings

  • Location
    kai tak, K3
  • Num holdings

    24

  • Value ($000)

    $121,265

  • Date Filed
    05/14/2026
  • Form type
    13F-HR
  • CIK
    0001782539
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

EVOMMUNE INC

COM SHS
30054Y107
$33.13M
27 %

1,441,032

---

MAPLIGHT THERAPEUTICS INC

COM
56565P103
$19.75M
16 %

971,253

---

LB PHARMACEUTICALS INC

COM SHS
50180M108
$15.55M
13 %

630,657

---

OCULIS HOLDING AG

ORDINARY SHARES
H5870P102
$9.33M
8 %

350,745

I
INCY

INCYTE CORP

COM
45337C102
$5.06M
4 %

53,742

B
BGNE

BEONE MEDICINES LTD

SPONSORED ADS
07725L102
$4.67M
4 %

15,722

R
RYTM

RHYTHM PHARMACEUTICALS INC

COM
76243J105
$4.27M
4 %

49,120

C
CELC

CELCUITY INC

COM
15102K100
$3.23M
3 %

28,300

A
ASND

ASCENDIS PHARMA A/S

SPONSORED ADR
04351P101
$3.11M
3 %

13,600

P
PCOR

PROCORE TECHNOLOGIES INC

COM
74275K108
$3.04M
3 %

53,299

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 24